James Plante, Founder and CEO

Jim Plante's interest in preventative health and technology was sparked when he worked for his father's medical technology company at an early age. He went on to earn a bachelor of science degree from Southern Illinois University in electrical engineering, founded four venture capital backed technology companies and launched more than 12 new product lines and services in the consumer products, automotive, wireless and service industries.

When Jim's father died from complications related to polycystic kidney disease, a genetic disease, it reignited Jim's interest in preventative health. Jim then started Pathway Genomics with the vision to make comprehensive genetic testing and personalized medicine accessible and affordable to all.

K. David Becker PhD, Chief Scientific Officer

Dr. Becker graduated from the University of California, Santa Barbara in 1979 and acquired his PhD in Biology from San Diego State University and U.C. San Diego in 1991. Dr. Becker has extensive experience in the genetics of Drosophila, mice and humans. During his postdoctoral training at UC San Diego Department of Medicine, he used mouse transgenic and knock-out models to study the link between defects in contractility and sudden cardiac death. After leaving UCSD, Dr Becker was a scientist at Mitokor working on quantitative analysis of changes in gene expression while studying the role of mitochondria in neurodegenerative disease and type II diabetes. Dr. Becker joined Torrey Pines Therapeutics, then Neurogenetics, in July 2000 and since that time has lead a team of scientists in the discovery and validation of genes that contribute to the pathogenesis of Alzheimer's disease. David and his research received public kudos for his efforts by receiving the #5 medical breakthrough of 2008 from Time Magazine.

Michael H. Cox, CIPP, Chief Privacy Officer

Michael joined Pathway Genomics to oversee the company's top priority, your privacy. As CPO, Michael is responsible for ensuring the protection and appropriate use of all sensitive customer information across the Pathway enterprise. He is a Certified Information Privacy Professional (CIPP) and member of the International Association Of Privacy Professionals (IAPP). As a self-described "health-nut" dedicated to quality and healthy living, Michael was attracted to Pathway's noble purpose of empowering individuals to improve their lives. He has a unique combination of enterprise risk management experience addressing strategic, reputational, legal, regulatory compliance, operational, information security and privacy risks. As Principal of SoCal Privacy Consultants, Michael established comprehensive, multi-state privacy and information security programs certified by an independent audit for compliance with all appropriate laws and regulations. At Capital One Auto Finance, he led the establishment of Capital One's world-class enterprise risk management program, including privacy. Michael has also held executive positions at Goal Financial, U.S. Bank, and HomeFed Bank where he oversaw operations functions and deployment of new technologies in support of existing and new products. Michael earned a B.S. in Business Administration from Virginia Tech.

Chris d'Eon, Marketing Vice President

With over 20 years marketing experience, Chris has been responsible for Internet, Radio, TV, Catalog, Direct Mail, Print and Brand advertising. As SVP at RealAge.com (now a division of Hearst, Inc.), Chris built a database of over 10 million health enthusiasts and worked with blue chip advertisers who paid to get their messages to niche health categories. Prior to RealAge, Chris worked as Marketing VP for ProFlowers.com (Provide Commerce), co-founder of Straight UP! Information Services (sold to ValueClick), Marketing Director at @Backup (recently purchased by Symantec) and Direct Marketing Manager for Intuit's TurboTax.

Ed MacBean, Product Management Vice President

Ed is responsible for the customer experience of Pathway Genomics. With over a decade of experience, Ed has launched innovative internet products that have been implemented at many of the leading health, not-for-profit and media companies in the country. Prior to joining Pathway, Ed was responsible for all aspects of product development at VMIX Media and led the product management team at Kintera (acquired by Blackbaud), named #1 in the 2005 San Diego Fast50 by Deloitte and Touche. At MedUnite, he developed insurance solutions for clients including LabCorp, Aetna and Cigna and at Medibuy he led efforts to provide e-commerce solutions for WebMD and Premier, Inc. Ed graduated from Duke University and earned a Master's Degree in Health Systems Management from Rush University.

Jim Woodman, Business Development Vice President

Jim Woodman is a visionary entrepreneur who brings over 25 years experience as event organizer, magazine publisher and founder/senior executive at The Active Network. As chief executive officer of Miami-based ActiveUSA.com, Woodman handled all aspects of managing the business, raising venture capital and hiring personnel. By late 1999, Woodman negotiated a 50% merger with Racegate.com and the two companies became The Active Network (active.com). As senior vice president of the merged entity, Woodman led every major acquisition that forms the foundation of The Active Network's product offerings. Today the Active Network employs over 2,500 and is projected to reach $300M in annual revenue in 2009.

Michael Nova, MD, Chief Medical Officer

Dr. Nova is currently a Chief Medical Officer of Pathway Genomics. Michael's scientific career began as research associate at the Salk Institute in the laboratory of Nobel Laureate Roger Guillemin where he studied the genetics and proteomics of Human Growth Factors. Michael was then the Founder/CEO of Discovery Partners Inc. (Nasdaq: DPII), which completed a successful $150M IPO and marketed wireless drug discovery technology and radiofrequency combinatorial chemistry to large Pharmaceutical companies. He then founded wireless sensory network company Graviton, where he was responsible for raising $60 million in capital from venture groups such as Kleiner Perkins and InQtel and additional corporate equity partners such as SUN, QUALCOMM, Siemens, Omron, Mitsui, Shell, and Motorola. Dr. Nova is also a practicing physician at CLIA licensed Pacific Dermatopathology labs.

Michael has over 20 issued patents, many in drug discovery technologies; has numerous publications in peer-reviewed journals, and is a Board Certified Dermatopathologist licensed in California. Dr Nova has degrees in Biochemistry, Physics, and Medicine from the University of California, Berkeley; and Albert Einstein University, New York and is a practicing physician at the CLIA-licensed laboratory of Pathology Associates of San Diego.

Sidney Stolz, Chief Growth Officer

Sid brings with him more than 25 years of experience providing top health-improvement companies with strategic oversight and product management. Most notable roles include his recent position as Executive Vice President with Healthcare Solutions, Inc., where he led and developed the overall corporate network strategy. Prior to this appointment, Sid held a number of executive positions, starting as Principal at Towers Perrin. In 1995, Sid joined UnitedHealth Group (UHG) as Senior Vice President of Delivery Systems Management and Product Development. He was promoted in 1997 to President and Chief Executive Officer of UHG’s Global Consulting division, responsible for all international operations. In 2001, Sid started at AdvancePCS as Senior Vice President and built a world-class management team responsible for revenues greater than six billion. In 2004, Sid saw the company through Caremark’s acquisition of AdvancePCS and was soon after promoted to Senior Vice President of Product Development and Marketing. He later was promoted to Executive Vice President and assisted with integration of the combined organizations.